Overview
Moderna Inc. (MRNA) is expected to experience an implied price movement of approximately 4.2% when it releases its quarterly earnings on July 31, 2026, prior to the market opening, according to options‑based calculations compiled by Bloomberg and reported by Reuters on 24 July 2026.
Historical Context
The company’s stock has exceeded the implied move in three of its last eight earnings announcements. Notable past outcomes include:
- On 1 August 2025, the share price fell 18.8% while the implied move was 7.6%.
- On 1 May 2026, shares declined 14.2% against an implied 9.2% move.
- On 13 February 2026, the stock rose 3.3% despite a 9.6% implied expectation.
- The largest post‑earnings swing in the past two years occurred on 1 August 2024, when the shares dropped 20.3% while the market had priced in a 7.9% move.
Recent Earnings Performance
The most recent earnings release on 1 May 2026 saw options traders anticipate a 9.2% price change; the actual result was a 14.2% decline, underscoring a tendency for the stock to move more sharply than implied in that instance. Conversely, the 13 February 2026 earnings produced a modest 3.3% gain, well below the 9.6% move that had been priced in.
Source Note
The article was generated with artificial‑intelligence assistance and subsequently reviewed by an editor, as indicated in the publication footer.